A NOVEL 53 KDA PROTEIN COMPLEXED WITH P210BCR-ABL IN HUMAN CHRONIC MYELOGENOUS LEUKEMIA-CELLS

被引:0
|
作者
LI, WJ [1 ]
KLOETZER, WS [1 ]
ARLINGHAUS, RB [1 ]
机构
[1] JOHNSON & JOHNSON BIOTECHNOL CTR INC,SAN DIEGO,CA 92121
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:559 / 566
页数:8
相关论文
共 50 条
  • [1] A 41-KILODALTON PROTEIN IS A POTENTIAL SUBSTRATE FOR THE P210BCR-ABL PROTEIN-TYROSINE KINASE IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS
    FREED, E
    HUNTER, T
    MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (03) : 1312 - 1323
  • [2] CRKL LINKS P210(BCR/ABL) WITH PAXILLIN IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS
    SALGIA, R
    UEMURA, N
    OKUDA, K
    LI, JL
    PISICK, E
    SATTLER, M
    DEJONG, R
    DRUKER, B
    HEISTERKAMP, N
    CHEN, LB
    GROFFEN, J
    GRIFFIN, JD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (49) : 29145 - 29150
  • [3] Curcumin inducing apoptosis and inhibiting expression of p210bcr-abl protein in human chronic myelogenous leukemia K562 cells
    Xu, JH
    Chen, YZ
    Huang, XW
    Xie, JM
    Huang, ZQ
    FASEB JOURNAL, 2000, 14 (08) : A1516 - A1516
  • [4] Growth inhibition of chronic myelogenous leukemia cells by ODN-1, an aptameric inhibitor of p210bcr-abl tyrosine kinase activity
    Schwartz, GN
    Liu, YQ
    Tisdale, J
    Walshe, K
    Fowler, D
    Gress, R
    Bergan, RC
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (04): : 329 - 339
  • [5] Alternative splicing leads to the frequent co-expression of p190BCR-ABL and p210BCR-ABL transcripts in the chronic phase of chronic myelogenous leukemia.
    KamelReid, S
    Lichty, BD
    Callum, J
    Keating, A
    BLOOD, 1996, 88 (10) : 912 - 912
  • [6] A NOVEL 53-KD PROTEIN COMPLEXED WITH P210BCR-ABI IN HUMAN CHRONIC MYELOGENOUS LEUKEMIA-CELL LINE-K562
    LI, WJ
    KLOETZER, WS
    ARLINGHAUS, RB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 445 - 445
  • [7] THE CHRONIC MYELOGENOUS LEUKEMIA SPECIFIC P210-PROTEIN IS THE PRODUCT OF THE BCR/ABL HYBRID GENE
    BEN-NERIAH, Y
    DALEY, GQ
    MESMASSON, AM
    WITTE, ON
    BALTIMORE, D
    SCIENCE, 1986, 233 (4760) : 212 - 214
  • [8] ANALYSIS OF P210BCR-ABL TYROSINE PROTEIN-KINASE ACTIVITY IN VARIOUS SUBTYPES OF PHILADELPHIA CHROMOSOME-POSITIVE CELLS FROM CHRONIC MYELOGENOUS LEUKEMIA PATIENTS
    MAXWELL, SA
    KURZROCK, R
    PARSONS, SJ
    TALPAZ, M
    GALLICK, GE
    KLOETZER, WS
    ARLINGHAUS, RB
    KOUTTAB, NM
    KEATING, MJ
    GUTTERMAN, JU
    CANCER RESEARCH, 1987, 47 (06) : 1731 - 1739
  • [9] DETECTION OF P210BCR-ABL IN MATURE GRANULOCYTES FROM PH1-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA PATIENTS BY AN IMMUNOBLOTTING METHOD
    KUWAO, F
    TAKAHASHI, I
    LEUKEMIA, 1993, 7 (08) : 1168 - 1173
  • [10] Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210BCR-ABL
    Berman, E
    Jhanwar, S
    McBride, M
    Strife, A
    Wisniewski, D
    Lambek, C
    Clarkson, B
    LEUKEMIA RESEARCH, 2000, 24 (04) : 289 - 297